THANE KREINER, Ph.D.
2010 - Present
Thane leads Miller Center for Social Entrepreneurship, the largest and most successful social enterprise accelerator in the world. Founded in 1997, Miller Center is one of three Centers of Distinction at Santa Clara University. We leverage the world's most innovative and entrepreneurial ecosystem and the Jesuit heritage of service to the poor and protection of the planet.
Oct 2011 - Dec 2017
Founder & CEO
Thane Kreiner, Ph.D. Consulting
Dec 2008 - Jun 2015
Board-level consulting services for life sciences firms and new ventures include strategy development and assessment, organizational design, C-level coaching, and corporate affairs, among others.
Nov 2012 - June 2014
Founder, President & CEO
Second Genome, Inc.
May 2009 - Oct 2010
Microbiome analysis company focused on improving environmental and human health.
Founder, President & CEO
Presage Biosciences, Inc.
Nov 2008 - Apr 2010
Founder and start-up CEO for new venture based on drug array technology invented at the Fred Hutchinson Cancer Research Center. Founded company, secured $3.1M Series A financing, licensed IP, formed core team, closed first pharmaceutical partnership deal, and hired Seattle-based CEO to lead company. www.presagebio.com
President & CEO
iZumi Bio, Inc (now iPierian)
Dec 2007 - Nov 2008
Start-up CEO for new venture focused on using iPS cell technology to transform drug discovery and regenerative medicine. Initiated R&D operations < 2 months after securing seed financing. Closed $20M Series A with KPCB and HCP. Secured core IP, formulated and executed innovative partnership with The Gladstone Institutes, and led public launch at ISSCR. Built a strong core team with shared vision, mission and values.
Senior Vice President
Dec 2002 - Jul 2007
Senior Vice President, Marketing and Sales, 4/06-4/07.
Led global commercial team of 280 staff with >$300M revenue and $68M budget. Formulated and implemented life sciences strategic business plan. Transformed technology-centric organization to global customer facing business teams.
Senior Vice President, Corporate Affairs, 12/02-4/06
Managed Government Relations, Regulatory Affairs, Corporate Communications, Quality, Public Affairs, Corporate Branding. Built high-performance corporate initiatives team to explore new market opportunities. Spearheaded corporate entry into Chinese market. Formulated and implemented long term regulatory and reimbursement strategy. Represented Affymetrix interests at governmental bodies including OECD, FDA, NCI. Led the development of corporate policy and positioning.
Aug 1998 - Dec 2002
Positions: Corporate Affairs, Corporate Operations and Communications, Sales and Marketing, Marketing and Strategic Planning
Managed various functions including: Sales, Marketing, PR, IR, Government Affairs, Quality, CIS, HR and Project Management. Built commercial (Sales, Marketing, etc.) organization to ~100 staff. Exceeded sales targets to achieve nearly 86% YOY revenue growth. Developed, implemented and led internal and external communications/PR strategy. Formulated public policy positions and managed Ethics Advisory Committee. Pioneered creation of sustainable and scaleable infrastructure in HR, CIS and Quality. Aggressively expanded product portfolio in partnership with R&D. Created and implemented access program for academic segment, now >60% of revenue.
Director/ Program Manager
Dec 1995 - Aug 1998
Director, Marketing and Project Management, 3/97-8/98. Led commercial strategy and R&D portfolio analysis processes. Developed goals and strategies for GeneChip® product lines. Managed pricing, channels, forecasting and manufacturing planning.
Program Manager, Strategic Marketing and Project Management, 12/95-3/97. Directed market and product planning activities, including market research. Drafted S-1 for $85 MM IPO (net) and played a major role in road show. Managed multiple cross-functional development and research teams simultaneously.
Project Manager/ Associate
Jun 1993 - Dec 1995
Project Manager, 4/94-12/95. Led cross-functional team that developed and first commercialized GeneChip system. Performed market research and strategic analyses for potential products. Leveraged R&D discoveries into development programs.
Associate, Business Development, 6/93-4/94. Prepared offering document for successful $21 million first-round private placement. Formulated pricing strategy and economic models for products. Initiated strategic planning and market research programs.
University of California, Berkeley
Feb 1988 - Feb 1991
Postdoctoral fellow, Department of Molecular and Cell Biology. Awarded Damon Runyon-Walter Winchell Cancer Fund Fellowship. Designed and implemented molecular analyses of secretory pathways.
Stanford University Graduate School of Business
1992 - 1994
Activities and Societies: Biotech/ Healthcare Club, Out4Biz
Stanford University School of Medicine
1983 - 1988
Dissertation title: Peptidergic Secretory Vesicles in Aplysia californica.
Thesis Advisor: Richard H. Scheller, Ph.D.
Awarded National Science Foundation Predoctoral Fellowship.
Instructor for upper-division Cellular and Molecular Neurobiology course
The University of Texas as Austin
1979 - 1983